# Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer

> **NCT03853187** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Zr-89 labelled durvalumab PET/CT
- **DRUG:** Durvalumab (MEDI4736)

## Key facts

- **NCT ID:** NCT03853187
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-19
- **Primary completion:** 2022-12-06
- **Final completion:** 2022-12-06
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-12-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03853187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03853187, "Imaging Tumor-infiltrating T-cells in Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT03853187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*